• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Prenatal Tdap Vaccination and Childhood Health Outcomes

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Maternal vaccination with the tetanus, diphtheria, and acellular pertussis vaccine (Tdap) is recommended in many countries to protect against infant pertussis
  • Laverty et al. (Pediatrics, 2021) evaluated the long-term safety of exposure to Tdap vaccination during pregnancy

METHODS:

  • Population-based retrospective cohort study
    • Ontario, Canada
    • Multiple province-wide health administrative databases
  • Population
    • All live births between April 2012 and March 2017
  • Exposure
    • Prenatal Tdap
  • Study design
    • Children were followed for up to 6 years (birth to end of follow-up)
    • Tdap vaccination during pregnancy was determined using vaccine-specific fee codes
    • Children in the exposure group were propensity score matched to unexposed children in a 1:5 ratio
  • Primary outcomes
    • Immune-related outcomes: Infectious diseases | Asthma
    • Nonimmunue-related outcomes: Neoplasm | Sensory disorders
    • Nonspecific morbidity: Urgent or inpatient health service use

RESULTS:

  • 625,643 live births during study period
    • Tdap exposure: 1.9% (12,045 births)
  • There were no significantly increased risks of adverse childhood outcomes with prenatal Tdap exposure
  • Tdap exposure was associated with a decreased risk of
    • Upper respiratory infections
      • Adjusted incidence rate ratio (RR) 0.94 (95% CI, 0.90 to 0.99)
    • Gastrointestinal infections
      • Adjusted incidence RR 0.85 (95% CI, 0.79 to 0.91)
    • Urgent and inpatient health service use
      • Adjusted incidence RR 0.93 (95% CI, 0.91 to 0.96)

CONCLUSION:

  • There was no association between prenatal Tdap exposure and adverse childhood health outcomes followed up to 6 years
  • The authors state

Exposure to Tdap during pregnancy was not associated with any increased risk of infection, asthma, neoplasm, sensory disorders, or urgent and inpatient health service use in children in their first 6 years of life, supporting the long-term safety of Tdap administration in pregnancy

Learn More – Primary Sources:

Health Outcomes in Young Children Following Pertussis Vaccination During Pregnancy

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Vaccination in Pregnancy: CDC Recommendations and ACOG Update
Results from the FluMum Study: Flu and Pertussis Vaccine Safety  
Are Tdap and Polio Vaccines Safe During Pregnancy?
Do Prenatal Tdap Vaccines Increase Risk for Autism?
More Evidence that Maternal Influenza Vaccination is Safe and Effective

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site